(NU/1868) The Provision of DNA Genotyping and Methylation Services in Developmental and Aged Musculoskeletal Tissues
Estimated value
£100k
Awarded value
£91k
Suppliers
1
Lots
1
Published
23 Mar 2023
Description
The Newcastle University Biosciences Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including this investigation into genetic influences upon DNA methylation during development, ageing and disease of the human hip. This project funded by Versus Arthritis aims to investigate how a transcription factor (RUNX2) is regulated epigenetically in development and in later life, contributing to a range of traits and diseases including height, hip shape, facial morphology, osteoarthritis, and osteoporosis. The purpose of this tender process is to engage a supplier to run Illumina MethylationEPIC and Infinium Global Screening Arrays to generate both DNA methylation and genotype data on 360 supplied DNA samples.
Scope
- Reference
- NCL001-DN652992-66897254
- Total value
- £100,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 10 Mar 2023 to 21 Aug 2023
- CPV classifications
- 73111000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 16 Feb 2023, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£91k
Award date
09 Mar 2023
Contract start
10 Mar 2023
Contract end
21 Aug 2023